SEC Form 4/A · accession 0001209191-15-028800
ImmunoCellular Therapeutics, Ltd. · IMUC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Anthony Gringeri
Officer — Senior VP Strategic Resources
Period of report
Feb 18, 2015
Accepted (ET)
Mar 24, 2015 · 4:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000822411
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 66,000 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reporting Person erroneously reported direct beneficial ownership of 66,000 shares. This report corrects his holdings to report the Reporting Person holds 66,000 shares indirectly via his trust.